Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,261,199 papers from all fields of science
Search
Sign In
Create Free Account
posatirelin
Known as:
pAad-Leu-Pro-NH2
, pyro-2-aminoadipoyl-leucyl-prolinamide
, L-6-ketopiperidine-2-carbonyl-leucyl-proline amide
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Narrower (2)
Piladox
RGH 2202
Broader (1)
Thyrotropin-Releasing Hormone
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2004
Review
2004
Treatment of vascular dementia: evidence from trials with non-cholinergic drugs
L. Pantoni
Journal of Neurological Sciences
2004
Corpus ID: 6009398
2002
2002
[TRH analogs at Gedeon Richter Ltd.: highlights of experimental and clinical efficacy of posatirelin].
A. Sarkadi
,
E. Kárpáti
Acta pharmaceutica Hungarica
2002
Corpus ID: 20934057
The chemical research for dissociation of the central nervous system effects of thyrotropin-releasing hormone (TRH) from its…
Expand
1997
1997
Effect of the thyrotropin releasing hormone analogue posatirelin (RGH 2202) on microanatomical changes induced by lesions of the nucleus basalis magnocellularis in the rat.
I. Panocka
,
G. Coppi
,
A. Maggioni
,
V. Olgiati
,
M. Sabbatini
,
F. Amenta
Drugs under experimental and clinical research
1997
Corpus ID: 1245437
The effect of 4 and 8 weeks treatment with 10 mg/kg/day of the thyrotropin releasing hormone analogue posatirelin (L-6…
Expand
1996
1996
Posatirelin in the treatment of vascular dementia: a double‐blind multicentre study vs placebo
L. Parnetti
,
L. Ambrosoli
,
+10 authors
U. Senin
Acta Neurologica Scandinavica
1996
Corpus ID: 24492706
Introduction– The usefulness of posatirelin (L‐pyro‐2‐aminoadipyl‐L‐leucyl‐L‐prolinamide), a synthetic peptide having modulatory…
Expand
1996
1996
Disposition of Posatirelin (3): Metabolites in Rats
Y. Matsunaga
,
K. Morimoto
,
H. Toda
,
Y. Terauchi
,
T. Fujii
,
H. Miyazaki
1996
Corpus ID: 88442474
After a single or repeated intravenous administration of [14C]posatirelin in rats, the structure of urinary metabolites and the…
Expand
1996
1996
Pharmacokinetic Profile and Endocrine Effects of Posatirelin Treatment in Healthy Elderly Subjects
G. Reboldi
,
L. Parnetti
,
+7 authors
U. Senin
Journal of clinical pharmacology
1996
Corpus ID: 25459378
The pharmacokinetics and endocrine effects of a therapeutic dose (10 mg/day) of posatirelin (L‐pyro‐2‐aminoadipyl‐L‐leucyl‐L…
Expand
1995
1995
Effects of RGH-2202 on behavioral deficits after focal cerebral ischemia in rats
Y. Noda
,
K. Furukawa
,
H. Kohayakawa
,
M. Oka
Pharmacology, Biochemistry and Behavior
1995
Corpus ID: 19772596
1995
1995
Posatirelin for the treatment of late‐onset Alzheimer's disease: a double‐blind multicentre study vs citicoline and ascorbic acid
L. Parnetti
,
L. Ambrosoli
,
+16 authors
U. Senin
Acta Neurologica Scandinavica
1995
Corpus ID: 36833784
Introduction ‐ Posatirelin (L‐pyro‐2–aminoadipyl‐L‐leucil‐L‐prolinamide) a new synthetic tripeptide with cholinergic…
Expand
1994
1994
Age-related alterations of skeletal muscle metabolism by intermittent hypoxia and TRH-analogue treatment.
O. Pastoris
,
M. Dossena
,
R. Arnaboldi
,
A. Gorini
,
R. Villa
Pharmacological Research
1994
Corpus ID: 41260619
The characteristics of the energy metabolism were evaluated in the gastrocnemius muscle from 3- and 24-month-old rats in normoxia…
Expand
1994
1994
Age-related changes by hypoxia and trh analogue on synaptic atpase activities
G. Benzi
,
A. Goroni
,
R. Arnaboldi
,
B. Ghigini
,
R. F. Villa
Neurobiology of Aging
1994
Corpus ID: 4025599
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE